1-10 of 10
Ahmad Naim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal genomic shifts associated with disease transformation in patients with polycythemia vera (PV) enrolled in REVEAL

Free
Stephen Oh, Michael Grunwald, TaeHyung (Simon) Kim, Erin Crowgey, J.E. Hamer-Maansson, Ahmad Naim, Valkal Bhatt, Jeffrey Zwicker
Journal: Blood
Blood (2025) 146 (Supplement 1): 3749.
https://doi.org/10.1182/blood-2025-3749
Published: 2025
Journal Articles

Real-world treatment duration of ruxolitinib and use of transfusion among 2268 patients with myelofibrosis: An analysis of the Medicare fee-for-service claims database

Free
Prithviraj Bose, Taylor Schwartz, Jennifer Repp, Alexis Garduno, Shayna Adams, Ahmad Naim, Valkal Bhatt, Jingbo Yu
Journal: Blood
Blood (2025) 146 (Supplement 1): 6391.
https://doi.org/10.1182/blood-2025-6391
Published: 2025
Journal Articles

Ruxolitinib duration of treatment and effect on phlebotomy use among 2369 patients with polycythemia vera: A real-world analysis of the Medicare fee-for-service claims database

Free
Naveen Pemmaraju, Alexis Garduno, Jennifer Repp, Shayna Adams, Taylor Schwartz, Ahmad Naim, Valkal Bhatt, Jingbo Yu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2826.
https://doi.org/10.1182/blood-2025-2826
Published: 2025
Journal Articles

Risk factors for progressive kidney impairment among patients with polycythemia vera (PV) are recapitulated and treatable in mouse models of PV

Free
Brandi Reeves, Marcelo Szymanski de Toledo, Fatima Trebak, Malgorzata Kasztan, Vimal Derebail, Rafal Pawlinski, Steffen Koschmieder, J.E. Hamer-Maansson, Ahmad Naim, Valkal Bhatt
Journal: Blood
Blood (2025) 146 (Supplement 1): 605.
https://doi.org/10.1182/blood-2025-605
Published: 2025
Journal Articles

Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease in an Expanded Access Program

Free
Parameswaran Hari, MD MRCP, Haris Ali, MD, Yi-Bin Chen, MD, Salman Fazal, MD, Tara K. Gregory, MD, Sarah M. Anand, MD, Ahmad Naim, MD, Dilan Paranagama, PhD, Valkal Bhatt, PharmD, Amy Blithe, RD, John F. DiPersio, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-140541
Published: 2020
Journal Articles

Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review

Free
Jingbo Yu, PhD, Becky Hanna, Dilan Paranagama, PhD, Jackson Tang, Ahmad Naim, MD, John P Galvin, MDMS,MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 1994.
https://doi.org/10.1182/blood-2019-127492
Published: 2019
Journal Articles

A Pooled Overall Survival (OS) Analysis of 5-Year Data from the COMFORT-I and COMFORT-II Trials of Ruxolitinib for the Treatment of Myelofibrosis (MF)

Free
Srdan Verstovsek, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Jason R. Gotlib, MD, Ruben A. Mesa, MD, Alessandro M. Vannucchi, MD, Jean-Jacques Kiladjian, MD PhD, Francisco Cervantes, MD PhD, William Sun, PhD, Jessy Gao, MA, Touchuan Dong, Ahmad Naim, MD, Prashanth Gopalakrishna, MBBS, MRCS, Claire N. Harrison, DM, FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 3110.
https://doi.org/10.1182/blood.V128.22.3110.3110
Published: 2016
Journal Articles

Impact of Myeloproliferative Neoplasms on Patients' Employment Status and Work Productivity in the United States: Results from the Living with MPN Patient Survey

Free
Jingbo Yu, MHA, PhD, Shreekant Parasuraman, BPharm, PhD, Dilan Paranagama, PhD, Ahmad Naim, MD, David Dubinski, MBA, Andrew Bai, MS, Ruben Mesa, MD FACP
Journal: Blood
Blood (2016) 128 (22): 4256.
https://doi.org/10.1182/blood.V128.22.4256.4256
Published: 2016
Journal Articles

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Free
Brady L. Stein, MD, Ahmad Naim, MD, Michael R. Grunwald, MD, Alison R. Moliterno, MD, Stephen T. Oh, MD PhD, Dilan Paranagama, PhD, Joseph A. Cordaro, PharmD, MBA, Hao Sun, MS, Shreekant Parasuraman, BPharm, PhD, Ralph V. Boccia, Ruben Mesa, MD FACP
Journal: Blood
Blood (2016) 128 (22): 1934.
https://doi.org/10.1182/blood.V128.22.1934.1934
Published: 2016
Journal Articles

Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study

Free
Hans Michael Kvasnicka, MD PhD, Juergen Thiele, MD PhD, Carlos E. Bueso-Ramos, MD PhD, William Sun, PhD, Ahmad Naim, MD, Smitha Svaraman, PhD, Jessy Gao, MA, Jason R. Gotlib, MD, Vikas Gupta, MD FRCP, FRCPath, Kim-Hien Dao, DO, PhD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1949.
https://doi.org/10.1182/blood.V128.22.1949.1949
Published: 2016